Toggle light / dark theme

Pioneering study finds predictive biomarker in lung adenocarcinoma

Although the transcriptomic signature of the tumor could not predict recurrence or the risk of progression, that of the TAN sample could successfully predict the recurrence of the disease and aid the stratification of patients into high-and low-risk groups.

This indicates the potential role of TAN tissue in future recurrence and its utility in predicting prognosis. However, TAN tissue could not accurately predict the formation of a new primary tumor.

HAARP artificial airglow may be widely visible in Alaska

Alaskans and visitors may be able to see an artificial airglow in the sky created by the High-frequency Active Auroral Research Program during a four-day research campaign that starts Saturday.

Scientists from the University of Alaska Fairbanks, Cornell University, University of Colorado Denver, University of Florida and Georgia Institute of Technology will conduct a variety of experiments at the UAF-operated research site.

The experiments will focus on the ionosphere, the region of the atmosphere between about 30 and 350 miles above the Earth’s surface.

Body changes detected up to eight years before inflammatory bowel disease diagnosis

Researchers at the Francis Crick Institute and Aalborg University in Copenhagen have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease and up to three years before a diagnosis of ulcerative colitis.

This means the beginnings of inflammatory diseases start a long time before symptoms occur, and in the future may provide an opportunity for doctors to take preventative action before symptoms begin, or prescribe medication when it will be most effective.

Crohn’s disease and ulcerative colitis are collectively known as inflammatory bowel diseases (IBD). They are incurable conditions which involve excessive inflammation in the gut, leading to symptoms like abdominal pain and diarrhea. Early diagnosis and treatment are key to improving outcomes, but nearly a quarter of the 25,000 people diagnosed each year in the UK wait over a year.

/* */